PureTech Health’s Vedanta Biosciences Granted Three New U.S. Patents for Therapeutics Based on Immune-Modulating Bacterial Consortia
PureTech Health’s Vedanta Biosciences Granted Three New U.S. Patents for Therapeutics Based on Immune-Modulating Bacterial Consortia
2017-05-16